TNC and pulmonary arterial hypertension: Schumann et al. demonstrated that plasma concentration of matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-4 and tenascin C, a matricellular protein, was elevated in the patients with PAH [16].